July 10, 2017

Dervieux et al. AR 2006 Pharmacogenomic and Metabolic Biomarkers in the Folate Pathway and Their Association With MTX Effects During Dosage Escalation

View Article
July 10, 2017

Innala et al. J Rheumatol. Antibodies Against Mutated Citrullinated Vimentin Are a Better Predictor of Disease Activity at 24 Months in Early Rheumatoid Arthritis Than Antibodies Against Cyclic Citrullinated Peptides

View Article
July 10, 2017

Costedoat-Chalumeau N, et al.Ann Rheum Dis. 2007. Very Low Blood Hydroxychloroquine Concentration as an Objective Marker of Poor Adherence to Treatment of Systemic Lupus Erythematosus

View Article
July 10, 2017

Costedoat-Chalumeau N, et al. Ann Rheum Dis. 2013. Hydroxychloroquine in SLE Results of a French Multicentre Controlled Trial (PLUS Study)

View Article
July 10, 2017

Sciascia et al. Journal of Thrombosis and Haemostasis. 2012. Clinical accuracy for diagnosis of APS in SLE

View Article
July 10, 2017

Oglesby et al. Appl Health Econ Health Policy. 2014. Impact of Early Versus Late SLE Diagnosis on Clinical and Economic Outcomes.

View Article
July 10, 2017

Narain, et al. Arch Intern Med. 2004. Diagnostic Accuracy for Lupus and Other Systemic Autoimmune Diseases in the Community Setting.

View Article
July 10, 2017

Petri et al. ACR Abstract. 2016. Complement C4d Split Products on Erythrocytes Are Associated With Composite Measure Of Disease Activity In SLE Subjects Receiving MTX and Hydroxychloroquine

View Article
July 10, 2017

Chiaro et al. Clinica Chimica Acta. 2011. Significant Differences between Anti-dsDNA IgG antibody assays for DX of SLE

View Article
July 10, 2017

Buyon et al. LSM 2016 – Reduction in EC4d and anti-C1q antibodies associate with clinical improvement in SLE.

View Article
July 10, 2017

Bentow et al. Lupus. 2016. International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA.

View Article
July 10, 2017

Wallace et al. LSM. 2016. Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products

View Article
July 10, 2017

Mossell et al. Open Rheum J. 2016. The Avise Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of SLE

View Article
Scroll to Top

Pin It on Pinterest

Share This